Back to All Services
Our Services
Health Economics Research
At Medicys we partner with, and are preferred suppliers to, many leading health economics firms who focus on measuring and valuing the outcomes of healthcare interventions and who seek to understand how to navigate regulatory frameworks and Health Technology Assessment processes.
Specifically, our pricing and market access specialists recruit, interview and report on our network of local, regional and national payers (and ex payers) and Payer Advising Key Opinion Leaders (PA-KOLs) on topics such as:
- Economic Evaluation
- Cost of illness
- Cost comparison, effectiveness, utility and benefit
- Thresholds and opportunity costs
- Value driven healthcare systems
- Health Policy and Regulatory frameworks
- Approval and labelling
- Pricing Policy and pricing Schemes
- Reimbursement and access
- Insurance systems and national healthcare
- Public spending and national health expenditures
- Procurement systems
- Risk sharing approaches
- Health Technology Assessment
- Systems and structure
- Value framework and dossier format
- Decisions and deliberative processes
Our projects in this discipline usually take the form of Web Assisted Telephone Depth Interviews (WATDIs), online groups or advisory boards (digital or in person).
Related Work
See all Work
health economics research
Alzheimer's Disease
+7
Alzheimer specialist nurses, old age psychiatrists, clinical biochemists, mental health services payers, lab procurement managers , neurologists, geriatricians
To gain an understanding of the current diagnostic pathways for AD (Alzheimer's Disease) and to the impact of the availability of potential diagnostic tests for Alzheimer’s Disease on clinical management. To understand the impact of the availability of potential tests for Alzheimer’s Disease on the lab. To gain an understanding of the current funding pathways for AD (Alzheimers Disease) and the funding of potential diagnostic tests for Alzheimer’s Disease. To gain an understanding of the current funding pathways for CSF and biomarker tests and the funding for potential diagnostic tests for Alzheimer’s Disease.
health economics research
To understand how payers find, evaluate and approve information for funding devices, and in their experience, what is most useful, or most frustrating. To understand how interactions with device manufacturers and diabetes medical device companies has changed since the pandemic, and about how things may developing over the next few years.
health economics research
Payers' experiences of purchasing medical products, and in particular the types of information resources used
health economics research
To understand perceptions of pricing of oral anti-diabetic treatment
Request a quote
